Using a prospective, repeated measures design, this study investigated the psychosocial functioning of patients and a close relative pre-and post-allogeneic and autologous bone marrow transplantation (BMT). All patients (n = 28) undergoing BMT in a 1 year period, and their relatives, were interviewed 1 week pre-transplant and at 3, 6 and 12 months post-BMT, using quantitative and qualitative measures. Pre-transplant data revealed a high level of anxiety (61% with moderate to severe anxiety), and a low level of depression (14% with moderate to severe depression). Twelve patients died in the study period. For the surviving patients there was a statistically significant improvement in physical, psychological and social functioning. Most relatives (88%) reported considerable psychological distress pretransplant and at 3 months post-transplant, but this was largely resolved by 12 months post-transplant. Significant correlations between the relative's distress and patient's physical and psychological wellbeing were observed at 3 months post-transplant, but not at the other assessment points. The findings from this study will help in counselling patients and their relatives as to what to expect in the year following BMT.
It has been well documented that bone marrow transplantation (BMT) is physically and psychologically demanding for patients. [1] [2] [3] [4] [5] [6] [7] The effects of BMT on donors 8 and on other family members has received less attention, 9 although evidence suggests considerable disruption to families. 10 Prospective longitudinal research that includes baseline assessments is required, 11 with greater emphasis on the process of psychosocial adjustment in both patients and families. 9, 11 One of the first prospective studies of psychosocial functioning in BMT showed that functioning was most impaired at 90 days post-transplant, with most aspects of physical and psychosocial functioning restored after 1 year. 12 A further prospective study reported similar findings, with little difference in physical and psychosocial status when assessed at pre-BMT and 1 year post-BMT. 13 While mean differences on pre-BMT and 1 year scores were not sig-nificant, the use of means obscures possible significant changes that individual patients may experience. 13 An analysis of change scores between pre-and post-transplant for individual patients suggests many experience substantial changes between these two assessments, 13 although detailed longitudinal studies of individual adaptation are scarce. 11 Qualitative research methods have rarely been used when studying BMT patients, particularly in a prospective longitudinal manner. Qualitative research is often viewed as the antithesis of quantitative research, 14 being somehow 'unscientific' and unreliable. 15 However, quantitative and qualitative methods are better viewed as complementary, 14 especially when health and illness issues are being examined in small numbers of patients, 16 and offer a useful addition to the usual quantitative methods. 14, 17 In order to address some of the recommendations concerning future research on psychosocial outcomes in BMT, 9, 11 and to examine individual functioning in detail, a repeated measures, prospective, longitudinal study of BMT patients and their families, using both quantitative and qualitative methods was designed. The aims of this study were: (1) to investigate the effects of BMT on patients and their families using a prospective, longitudinal design; and (2) to use qualitative interviews to examine the recovery process of patients and the role played by relatives.
Patients and methods

Patients
Consecutive recipients of BMT in a 1 year period (n = 28) in St James's Hospital, Dublin, were included in the study. There were no exclusion criteria and all patients agreed to participate. Patients were interviewed at four points during the study, the week before transplant and at 3, 6 and 12 months post-transplant. The post-BMT time points were chosen to reflect stages in the recovery process, most patients being discharged by 3 months, commencing withdrawal of immunosuppressive therapy at 6 months and the pre-morbid state close to being achieved by most, at 12 months. Twelve patients died during the course of the study and all surviving patients were followed up, 15 at 3 months post-BMT, 12 at 6 months and the 14 surviving patients were interviewed at 1 year post-transplant (two patients died 13 months after transplant and were not interviewed at 12 months). Following the interview with the patient a request was made to interview a close relative, not the donor. Relatives were selected in order of kin relationship to the patient and if they had close contact with the patient at the time of the transplant; spouse/partner if the patient was married (n = 18), parent if the patient was unmarried and lived at home (n = 5), and a sibling of adult unmarried patients (n = 2). Twenty-five (89%) of the 28 relatives were interviewed before the transplant (one patient refused permission to contact his relative and two relatives were unavailable for interview) and were then followed; 13 at 3 months, 10 at 6 months and 11 at 1 year post-transplant. If the patient died the relative was no longer interviewed. The characteristics of patients and relatives are detailed in Table 1 . Sixty-one per cent of patients undergoing transplant were male; 76% of the interviewed relatives were female.
Methods
Quantitative measures for patients and relatives: Patients completed the Hospital Anxiety and Depression Scale (HADS), 18 the Rotterdam Symptom Checklist (RSCL), 19 the social functioning status and overall quality of life modules from the EORTC Core Quality of life Questionnaire 20 and a short series of questions relating to sexual activity. The HADS is a short 14-item questionnaire which yields a depression subscore and an anxiety subscore. These are used to categorise patients into 'cases', that is, having clinically significant anxiety or depression which would be diagnosed as such by a psychiatrist, 'sub-cases' or probable cases, and 'non-cases'. It has been shown to measure change over time 21 and has been well validated with cancer patients. 22, 23 The Rotterdam Symptom Checklist (RSCL) is a selfcompleted checklist of 30 symptoms rated on a four-point Likert scale and yields a physical subscore and a psychological subscore. The RSCL has been shown to be a reliable and valid measure. 19 Both the HADS and the RSCL are reported as having good predictive value and accuracy for screening for psychiatric morbidity in cancer patients. 23 The European Organization for Research and Treatment of Cancer (EORTC) developed a modular instrument in 1988 24 to assess the quality of life of cancer patients. This measure has been shown to be acceptable and valid; the scales assessing distinct components of the quality of life construct, and changing over time in the expected direction in response to treatment. 20 As separate, more detailed measures were used to assess physical and psychological wellbeing, only the social functioning and global measures of physical wellbeing and quality of life from the EORTC measure were used.
The questions on sexual functioning consisted of four related to: interest in sex, activity, ability and satisfaction, all rated on a three point scale denoting increased, same and decreased. Three questions relating to: pain during intercourse, infertility and awareness of infertility were rated yes/no. A final question on the patient's reaction to future infertility was rated on a seven point scale from 'not upset' to 'very upset'.
The 12-item General Health Questionnaire (GHQ) 25 was completed by relatives. This is a short, self-completed questionnaire on which respondents assess their present mental and emotional condition by reference to their normal state, and rate this on a four-point Likert scale. The scores are summed to determine if the individual lies above or below the 'GHQ stress threshold'; those above classified as distressed and those below classified as normal.
Qualitative measures for patients and relatives:
Patients were interviewed by one of us (FK), using a semi-structured interview 16 which we called the BMT Impact Schedule, to elicit qualitative data on their experience of the BMT. This interview was compiled following a review of the BMT quality of life literature and in-depth interviews 16 with patients who had already undergone BMT and their relatives. This interview enabled a more detailed exploration of issues than was possible with self-completed questionnaires. The interview included sections on available support and the effect of BMT on social activities, work and family life. Each section of the interview started with a question on one of these domains which was rated on a four-point Likert scale 26 ('not at all' to 'very much'), and was followed by an open-ended question 16 to elicit the qualitative response, which was recorded in detail. The BMT Impact Schedule was also used to interview relatives and to obtain qualitative data concerning their experience of the BMT process and its effects on them and the patient.
Statistical analysis
SPSS for windows was used to analyse the quantitative data, using repeated measures analysis of variance (ANOVA) and bivariate correlations. Content analysis 27 was used to analyse the responses from the semi-structured interviews. Cross-case analysis was used for the assessments at each time point as there was a small amount of qualitative data for each interview. A simple codebook consisting of items such as emotional response of patient, description of practical consequences etc. was drawn up as part of the content analysis. The validity of the data were established by cross-checking with the quantitative results where appropriate. For example, the description of the patient's emotional response was checked with their HADS and RSCL scores. This showed that the qualitative data presented a valid account of the effects of BMT. The interviewer was not part of the clinical team caring for the patients and thus was impartial in terms of the study findings and possible influences on the patients. The same person interviewed patients and coded the data; therefore issues of inter-rater and inter-coder agreement did not arise. Table 2 shows a cross-sectional description of the quantitative measures for patients who were available for interview at the different assessment points. Anxiety pre-transplant was considerable, with 61% of patients being either cases or sub-cases. This anxiety was largely resolved at 3 months post-BMT, and remained so at 6 months and 1 year. Of the 17 cases of anxiety pre-transplant, four were still cases at The two cases at 12 months first developed depression at 3 months post-transplant. The mean anxiety and depression scores showed that while the 12 month scores were lower than pre-BMT, the decrease did not occur steadily over the year but showed increases and then decreases.
Results
Quantitative measures
Patients' self-ratings of physical wellbeing and quality of life (EORTC) were poorest at 3 months post-transplant and recovered to pre-BMT levels by 12 months. Both interest in sex and sexual activity were lowest at 3 months posttransplant with 60% reporting no interest and decreased activity. By 12 months post-transplant only two patients were still experiencing sexual problems. Five patients (36%; three male, two female) were upset by their infertility. All patients were informed of the implications for their fertility of the treatment they would receive. However, only half of the study patients reported that they knew their treatment had caused infertility and that they had been informed of this before treatment commenced, 21% reported they 'didn't know', and another 21% did not respond to this question.
The RSCL physical and psychological scores decreased from pre-BMT to 6 months. While a slight increase was seen in the 12 month scores, these were still well below the pre-BMT level. Social functioning (EORTC social functioning score) was poorest at 3 months but decreased to below pre-BMT by the 12 month assessment.
The mean scores in Table 2 cannot be compared over time (as not all patients were available at every assessment point). The means illustrate the level of problems experienced at four time points in a population of patients and relatives in the year following transplant. Table 3 shows the significance of changes in these scores for those patients who had assessments at all four study points. Scores on all quantitative measures decreased over the 12 month study period, and this reduction was statistically significant for physical functioning, general psychological well-being and social functioning.
For some patients, psychological, physical and social functioning were very closely associated over the 12 month period, although this was not the case for all patients. Social functioning was most strongly related to physical health pre-transplant (r = 0.55, P = 0.005). Depression and physical health were most strongly correlated at 6 months posttransplant (depression and RSCL physical score r = 0.79, P = 0.002). Correlations at the other assessment points were not significant.
Results from qualitative interviews
The effects on the patient's family, work and social life were greatest pre-transplant and at 3 months post-transplant, with few problems reported at 6 and 12 months (Table 4) . For example, 64% reported that their family life was affected 'quite a bit' or 'very much' pre-transplant, 60% at 3 months, 33% at 6 months and 7% at 12 months. The patient who had problems at 12 months had reported these problems pre-BMT.
Over half (57%) of the 14 survivors had excellent support from family and/or friends throughout the year, and most (87% pre-BMT, 79% at 12 months) had at least one confidant to discuss emotional problems or difficulties through the year. Patients differed in relation to support and coping styles. Half of the survivors (n = 7) adopted very positive attitudes towards their illness as a means of coping. The patients in this group used descriptions like 'I have to fight this' and 'I'll put up with anything to get better'. In contrast, the coping styles of the other seven surviving patients were characterised by denial, withdrawal and avoidance. These patients had difficulty in acknowledging or describing emotions, especially fear or depression. For Table 3 Longitudinal outcome measures for patients (n = 10) and relatives (n = 7) with data at all assessment points example, one patient flatly refused to discuss his illness, feelings or treatment, almost aggressively refused information and acted as if he was in hospital for a relatively minor procedure. The two cases of depression at 12 months post-transplant were in this group.
Relatives
Before the transplant most relatives (88%) scored above the GHQ stress threshold (Table 2) . At 3 months the majority of relatives still experienced considerable distress (62%). By 6 months post-transplant 40% were distressed and by 12 months this had reduced to 18%. Both of these relatives had been cases pre-BMT and one had a long-standing psychological problem which continued throughout the period of the study. The mean GHQ score reduced significantly over time (Table 3 ). All relatives received considerable practical and emotional support from other family members and friends. An examination of correlations between the patient's scores (RSCL and HADS) and the relative's GHQ scores at the four assessment points revealed that strong correlations occurred at 3 months post-transplant: GHQ and RSCL physical functioning r = 0.84 (P Ͻ 0.005), GHQ and RSCL psychological wellbeing r = 0.88 (P Ͻ 0.002), GHQ and HADS anxiety r = 0.73 (P Ͻ 0.03) and GHQ and HADS depression r = 0.72 (P Ͻ 0.03). The relationships between GHQ scores in relatives and patient scores at the other assessment points, were very weak, with negative correlations seen at 6 and 12 months post-transplant.
Results from relative's qualitative interviews
The effects on different aspects of relative's lives were greatest pre-BMT and were at very low levels by 12 months post-transplant (Table 4 ). All the relatives interviewed at pre-and 3 months post-BMT, felt that their most important function was to support and 'be there' for the patient, and over half (56%) reported completely 'taking over' the tasks and roles of the patients. All relatives reported receiving excellent support, from family, neighbours and friends, with many being given unconditional time off from work. Most (68%) reported that this support was what 'kept them going'. Between 3 and 6 months post-transplant all patients were back at home. At this point relatives expected life to resume and get 'back to normal' and were surprised at the Interference ratings equal a score of 2 (quite a bit) or 3 (very much) on each life domain.
reluctance of some patients to do this, and their seeming unhappiness and irritability. This was a source of tension and conflict for almost half (45%) of relatives, and this was still the case at 12 months post-transplant, although tension was not as great. A further source of tension in seven families (64%) was feelings of resentment or frustration for both patients and relatives at the continued dependence of the patient, and was particularly noticeable in families where the patient was unmarried.
Discussion
This is one of the few investigations to include repeated observations of BMT patients and their relatives in a prospective longitudinal design. Significant improvements in patient's physical, psychological and social functioning were observed at 12 months post-transplant compared to pre-transplant scores. The use of repeated observations enabled individual changes in functioning and the adaptation process over time to be examined. 9, 11 With this method the variability due to differences between patients can be eliminated from the experimental error. Thus, each patient acts as his/her own control and small numbers of patients can be reasonably studied to determine significant outcomes. BMT is associated with significant morbidity and mortality in the first 3 months and results reported here pertain only to patients who survived and were available for interview.
In interpreting the quantitative outcome data, use was made of the qualitative interviews with patients and relatives in order to create a more complete picture 17 of the process of psychosocial adjustment in the year following BMT. We found physical, psychological and social functioning of patients to be most impaired at 3 months posttransplant. One other study has examined BMT patients at this time and reported similar results. 12 Our results show that considerable impairment is also present at 6 months post-transplant and the qualitative accounts of the BMT experience from patients revealed that it was only in the last few months of the year following transplant that their health, psychological well-being and life in general began to recover. This information regarding the 'timing' of recovery, and the differential recovery rates for different aspects of functioning can only be revealed by a prospective, repeated measures design. It indicated at what time periods different interventions might most appropriately be implemented, and might also help to avoid unnecessary intervention.
Difficulties in sexual functioning were noted pre-and immediately post-BMT, although these difficulties were resolved for most patients by 12 months post-BMT. It was surprising that only half of the patients seemed to be aware that their treatment had caused infertility, as this consequence of treatment had been fully discussed with all patients in pre-BMT counselling sessions. It may be that pre-BMT patients are overwhelmed with the weight and significance of the information they receive and do not fully take in the information regarding infertility. This finding has practical implications for how information is imparted to patients and their relatives pre-BMT.
Scores from the HADS showed that psychological health was slowest to recover, with many patients reporting feeling psychologically worst when their physical health had significantly improved. This 'disparity' in rates of physical and psychological recovery has been reported in other cancer patients post-treatment. 28 Data from the qualitative interviews suggested that when the physical danger had passed, issues such as the significance of receiving transplanted material began to have an impact. Patients needed some time to come to terms with or resolve these issues before they felt fully recovered. This has been noted in a previous study 12 and corresponds with stages 7 and 8 of BMT proposed by Brown and Kelly. 29 The temporary nature of emotional difficulties, particularly anxiety and depression, has been noted for hospitalised cancer patients, 30 but the high prevalence of problems in BMT patients raises issues such as what can be considered an 'acceptable level' of psychological distress, when intervention should be initiated, and what form these interventions should take. Psychological problems such as anxiety and depression in BMT can be due to several fac-tors. 30 Indeed, it may be considered 'normal' for cancer patients to have some increase in anxiety and depression and it can be difficult to decide when these responses are normal and when they should be considered pathological or dysfunctional. 30 The results from this study provide some data as to what might be expected at different points following BMT, and may facilitate a decision as to whether a problem is within expectations, or is pathological and adversely influencing recovery. This is one of the few studies to examine the effect of the BMT procedure on close relatives of the patient other than the donor. 10 As might be expected, distress in the relative was greatest before and immediately following the transplant. The GHQ scores showed that this distress resolved quite quickly for most relatives. When physical improvement was seen in the patient, relatives felt that the episode was over and they, the patient and their family could resume their normal life. In some cases this led to the patient and relative being 'out-of-step', because it was only at this point that most patients were beginning their psychological adjustment process. This often led to tensions within families, with relatives reporting not being able to understand the patient's seeming reluctance to 'get on with life' now that they were (physically) well. The correlation analysis of quantitative scores supports these qualitative results, with significant relationships between patient's and relative's scores seen at 3 months post-transplant but not after this point. One of the few studies to examine families of BMT patients, reported that following the disruptions in family life and role performance, patients and families may need to undergo a reintegration process. 10 This study has demonstrated the benefits of a prospective longitudinal design in studying psychosocial functioning in BMT patients. It also shows the usefulness of including both qualitative and quantitative measures in a study of BMT patients. The importance of including relatives emerged in this study and the information gained will help in counselling BMT patients and their relatives. Larger studies looking at the process of adaptation may enable more detailed characterisation of outcome in order to help in the prediction of problems and the initiation of appropriate intervention.
